Histogen Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Histogen Stock Summary

Histogen competes with Eliem Therapeutics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. Histogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.

Histogen Key Financial Ratios

Histogen Key Balance Sheet Accounts

Histogen Key Income Statement Accounts

Histogen Key Cash Accounts

Histogen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Histogen's current stock value. Our valuation model uses many indicators to compare Histogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Histogen competition to find correlations between indicators driving Histogen's intrinsic value. More Info.Histogen is rated # 2 in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . At this time, Histogen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Histogen's earnings, one of the primary drivers of an investment's value.

Histogen Systematic Risk

Today, most investors in Histogen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Histogen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Histogen growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Histogen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Histogen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Histogen based on widely used predictive technical indicators. In general, we focus on analyzing Histogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Histogen's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Histogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Histogen Stock, please use our How to Invest in Histogen guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Histogen. If investors know Histogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Histogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Histogen is measured differently than its book value, which is the value of Histogen that is recorded on the company's balance sheet. Investors also form their own opinion of Histogen's value that differs from its market value or its book value, called intrinsic value, which is Histogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Histogen's market value can be influenced by many factors that don't directly affect Histogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Histogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Histogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Histogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.